FDA Inspection 1013139 — Syneos Health, Inc
The FDA completed an inspection of Syneos Health, Inc on May 11, 2017 in Farnborough. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 11, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Farnborough (United Kingdom)
Additional Details
Sponsor, Contract Research Organization